Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 5/20 | 0.58 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.57 |
| ▸ | TYMP | P19971 | 1/20 | 0.45 |
| ▸ | HPRT1 | P00492 | 5/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | PNP | P00491 | 1/20 | 0.38 |
| ▸ | POLA1 | P09884 | 1/20 | 0.37 |
| ▸ | POLG | P54098 | 1/20 | 0.37 |
| ▸ | EP300 | Q09472 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29505155 | 0.88 | FGFR1 (0.51) | FGFR1SLC22A6HPRT1PNPEP300 | |
| SCHEMBL15531740 | 0.84 | POLB (0.56) | FGFR1SLC22A6POLBPOLA1POLG | |
| SCHEMBL8896100 | 0.82 | FGFR1 (0.57) | FGFR1SLC22A6HPRT1PNPEP300 | |
| SCHEMBL8714133 | 0.81 | FGFR1 (0.56) | FGFR1SLC22A6HPRT1PNPEP300 | |
| SCHEMBL16037312 | 0.80 | FGFR1 (0.50) | FGFR1SLC22A6HPRT1POLBPOLA1 | |
| SCHEMBL30364353 | 0.79 | FGFR1 (0.46) | FGFR1SLC22A6EP300 | |
| SCHEMBL20641457 | 0.78 | FGFR1 (0.40) | FGFR1SLC22A6EP300 | |
| SCHEMBL5802198 | 0.78 | FGFR1 (0.71) | FGFR1SLC22A6EP300 | |
| SCHEMBL18665283 | 0.78 | FGFR1 (0.41) | FGFR1SLC22A6EP300 | |
| SCHEMBL20586318 | 0.76 | FGFR1 (0.54) | FGFR1SLC22A6EP300 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581714-A1 | SYSTEMS AND METHODS FOR AN ADAPTIVE POWER SYSTEM STABILIZER (PSS) | General Electric Technology GmbH (CH) | 2025-07-09 | — | — | EP | claimed |
| WO-2025109431-A1 | A METHOD FOR DETERMINING A TORQUE DISTRIBUTION BETWEEN A FRONT AXLE AND A REAR AXLE IN A VEHICLE HAVING AN ELECTRIC POWERTRAIN | MASERATI S.P.A. (IT) | 2025-05-30 | — | — | WO | claimed |
| CN-119948717-A | System and method for adaptive Power System Stabilizer (PSS) | 通用电气技术有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119757880-A | Motor dielectric loss testing method considering stator-rotor ditching effect and axial flow | 哈尔滨工业大学 | 2025-04-04 | — | — | CN | claimed |
| CN-114640279-B | Variable frequency motor loss modeling method applicable to energy regulation and control of air-conditioning-like system | 广西大学 | 2025-03-14 | — | — | CN | claimed |
| US-12197951-B1 | Mobile edge computing (MEC) task unloading method with cache mechanism | CHENGDU UNIVERSITY OF INFORMATION TECHNOLOGY (CN) | 2025-01-14 | — | — | US | claimed |
| WO-2024091849-A1 | SYSTEMS AND METHODS FOR AN ADAPTIVE POWER SYSTEM STABILIZER (PSS) | GE INFRASTRUCTURE TECHNOLOGY LLC (US) | 2024-05-02 | — | — | WO | claimed |
| US-20240142926-A1 | SYSTEMS AND METHODS FOR AN ADAPTIVE POWER SYSTEM STABILIZER (PSS) | GE INFRASTRUCTURE TECHNOLOGY LLC | 2024-05-02 | — | — | US | claimed |
| EP-4305018-A2 | SYNTHESIS OF OMECAMTIV MECARBIL | Amgen Inc. (US) | 2024-01-17 | — | — | EP | claimed |
| CN-117157274-A | Synthesis of olmesartan Mo Kabi mol | 安进股份有限公司 | 2023-12-01 | — | — | CN | claimed |
| US-11702380-B2 | Synthesis of omecamtiv mecarbil | AMGEN INC. (US) | 2023-07-18 | — | — | US | claimed |
| CN-110799503-B | Synthesis of Meicartine | 美国安进公司 | 2023-06-27 | — | — | CN | claimed |
| US-20220298099-A1 | SYNTHESIS OF OMECAMTIV MECARBIL | AMGEN INC. | 2022-09-22 | — | — | US | claimed |
| WO-2022194640-A1 | ROTARY ELECTRIC MACHINE | VALEO EQUIPEMENTS ELECTRIQUES MOTEUR (FR) | 2022-09-22 | — | — | WO | claimed |
| CN-113449391-B | Energy optimal configuration and evaluation method based on thermoelectric coupling | 中国航空工业集团公司沈阳飞机设计研究所 | 2022-09-20 | — | — | CN | claimed |
| WO-2022192414-A2 | SYNTHESIS OF OMECAMTIV MECARBIL | AMGEN INC. (US) | 2022-09-15 | — | — | WO | claimed |
| CN-114640279-A | Variable frequency motor loss modeling method suitable for energy regulation and control of similar air conditioning system | 广西大学 | 2022-06-17 | — | — | CN | claimed |
| CN-114520772-A | 5G slice resource scheduling method | 广州杰赛科技股份有限公司 | 2022-05-20 | — | — | CN | claimed |
| CN-114285076-A | Virtual inertia configuration method considering dynamic frequency response process | 国网青海省电力公司经济技术研究院 | 2022-04-05 | — | — | CN | claimed |
| US-6060463-A | Treatment of conditions of abnormally increased intraocular pressure by administration of phosphonylmethoxyalkyl nucleoside analogs and related nucleoside analogs | Freeman, William (US) | 2000-05-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702380-B2 | Synthesis of omecamtiv mecarbil | SI, MTHFD2, DPYD | FGFR1 2016/4885SLC22A6 812/4885TYMP 4/4885 |
| US-20220298099-A1 | SYNTHESIS OF OMECAMTIV MECARBIL | SI, MTHFD2, DPYD | FGFR1 2016/4885SLC22A6 812/4885TYMP 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.